«Kidney Cancer

Below is an extended Kidney Cancer patents listing. Click here to return to the Kidney Cancer main in depth entry.

Patents :
US Patent No.	Title
7399829	Variants of RANKL protein
7407660	Methods and compositions for selective modulation of vascularization
7407755	Determining a predisposition to cancer
7407784	L-amino acid oxidase with cytotoxic activity from Aplysia punctata
7407951	Pyrrolobenzodiazepines
7407967	Cyclopamine analogues and methods of use thereof
7410969	Antitumoral analogs of ET-743
7410975	Small molecule toll-like receptor (TLR) antagonists
7410976	Spirochromanone derivatives
7411051	Antibodies to HDPPA04 polypeptide
7412285	Method and device for treating cancer with electrical therapy in conjunction with chemotherapeutic agents and radiation therapy
7405290	Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
7405287	Method of treating a cancer
7405277	Antibodies against monocyte chemotactic proteins
7402317	Anti-cancer vaccine
7402324	Process for preparing aqueous extracts of plants and extracts so obtained
7402389	Compositions and methods for prognosis of cancers
7402399	Receptor tyrosine kinase signaling pathway analysis for diagnosis and therapy
7402727	Non-human animal exhibiting bone metastasis of tumor cells
7405061	Antigen PIPA and antibodies that bind thereto
7405194	Therapeutic agents and methods of use thereof for the treatment of melanoma
7405221	Substituted pyrimidines
7405226	Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
7405227	Treatment of cancer
7413727	Contrast agents
7414057	Piperazine urea derivatives as melanocortin-4 receptor agonists
7425329	Methods for treating bone cancer pain by administering a nerve growth factor antagonist
7425548	Materials and methods for immune system stimulation
7425606	Method for screening peptides for use in immunotherapy
7425619	Fc.gamma.RIIB specific antibodies and methods of use thereof
7425623	Antibody with specificity for colon cancer
7425651	Jasmonate derivative compounds, pharmaceuticals compounds and methods of use thereof
7427399	Antibodies and related molecules that bind to 161P2F10B proteins
7427400	Methods of cancer diagnosis and therapy targeted against a cancer stem line
7427605	Inhibitors of ribonucleotide reductase subunit 2 and uses thereof
7427659	Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction
7423116	Pentapeptide compounds and uses related thereto
7423067	Diphenyl cyclopentyl amides as cannabinoid-1 receptor inverse agonists
7423007	Cxcr4 antagonist and use thereof
7416727	Polypeptide variants with altered effector function
7419663	Treatment of complement-associated disorders
7419805	Polynucleotides encoding S99T interferon gamma polypeptide variants and means of expression
7419990	Piperidine derivatives as melanocortin-4 receptor agonists
7420000	Amino phosphonate and amino bis-phosphonate derivatives
7420029	Tissue-specific transporter inhibitor
7420051	Synthetic process for the manufacture of an ecteinaschidin compound
7422741	VEGFR-3 fusion proteins
7422752	Mutant forms of EtxB and CtxB and their use as carriers
7422899	Antibodies to the human prolactin receptor
7428554	System and method for determining matching patterns within gene expression data

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.